Sebi has a comprehensive framework in the form of Alternative Investment Funds (AIFs) Regulations to bring PEs and VCs, under its ambit of inspection and investigation, and said all these funds have to register with the regulator now. At present, PE and VC funds have the option not to register with Sebi. However, considerable confusion existed about the rules of AIFs, since Sebi did not specifically say if these rules applied only to India domiciled funds or also those based outside India.
Deutsche Securities Mauritius Limited has sold its 1.95 percent stake in Jubilant Life Sciences Limited, a global life sciences and pharmaceutical company, for just over INR122 crore. The sale of the stake was performed as an open market transaction, and purchased by Citigroup Global Markets Mauritius Pvt. Ltd.